Last $2.28 USD
Change Today +0.26 / 12.87%
Volume 704.9K
RIGL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas A. Raffin M.D.

AgeTotal Calculated CompensationThis person is connected to 40 board members in 3 different organizations across 6 different industries.

See Board Relationships
67--

Background*

Dr. Thomas A. Raffin, also known as Tom, MD is a Co-Founder at Rigel Pharmaceuticals, Inc. He co-founded Rigel Pharmaceuticals, Inc. in 1996. Dr. Raffin is also a Senior Partner at Telegraph Hill Partners. He joined Telegraph Hill Partners as a Partner in 2001. Dr. Raffin is an Advisor to numerous other companies. He founded the firm. Over the past two decades he has worked extensively in the healthcare and medical device sectors. Dr. Raffin was an Advisor to Cell Therapeutics ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

Director
Former Director
1999-Present
Director, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee
2006-Present
Director
2007-2013
Former Director
2008-N/A
Director

Education*

MD
Harvard University
BA
The Leland Stanford Junior University
MD
Stanford University School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.28 USD +0.26

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.